Helix BioPharma Corp. announced that Heman Chao has notified the board of directors of the company of his intention to step down from the position of Chief Scientific Officer and member of the Board, effective September 1, 2021. As of September 1, 2021, Mr. Chao will assume the position of Chair of the company's Scientific Advisory Board.